Geneos Therapeutics

OverviewSuggest Edit

Geneos Therapeutics engages in the development, and commercialization of DNA-based immunotherapies and vaccines that transform the treatment and prevention of cancer and infectious disease. The Company leverages genomics, artificial intelligence, and cancer immunotherapy to develop personalized immunotherapies against tumor-specific neoantigens which arise from gene mutations in cancerous cells.

TypePrivate
HQPlymouth Meeting, US
Websitegeneostx.com

Locations

Geneos Therapeutics is headquartered in
Plymouth Meeting, United States

Location Map

Latest Updates

Employees (est.) (Feb 2019)2

Geneos Therapeutics Office Locations

Geneos Therapeutics has an office in Plymouth Meeting
Plymouth Meeting, US (HQ)
660 W Germantown Pike #120
Show all (1)

Geneos Therapeutics Financials and Metrics

Summary Metrics

Geneos Therapeutics total Funding

$10.5 m

Geneos Therapeutics latest funding size

$10.50 m

Time since last funding

a year ago

Geneos Therapeutics investors

Geneos Therapeutics's latest funding round in February 2019 was reported to be $10.5 m. In total, Geneos Therapeutics has raised $10.5 m
Show all financial metrics

Geneos Therapeutics Online and Social Media Presence

Embed Graph

Geneos Therapeutics Frequently Asked Questions

  • How many employees does Geneos Therapeutics have?

    Geneos Therapeutics has 2 employees.

  • Who are Geneos Therapeutics competitors?

    Competitors of Geneos Therapeutics include Kiromic, Sareum Holdings and Akrevia Therapeutics.

  • Where is Geneos Therapeutics headquarters?

    Geneos Therapeutics headquarters is located at 660 W Germantown Pike #120, Plymouth Meeting.

  • Where are Geneos Therapeutics offices?

    Geneos Therapeutics has an office in Plymouth Meeting.

  • How many offices does Geneos Therapeutics have?

    Geneos Therapeutics has 1 office.